Skip to Content
Merck
CN

E1501

Benzocaine

≥99% (HPLC)

Synonym(s):

4-Aminobenzoic acid ethyl ester, Ethyl 4-aminobenzoate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C9H11NO2
CAS Number:
Molecular Weight:
165.19
UNSPSC Code:
51271900
NACRES:
NA.25
PubChem Substance ID:
EC Number:
202-303-5
Beilstein/REAXYS Number:
638434
MDL number:
Assay:
≥99% (HPLC)
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥99% (HPLC)

form

powder

solubility

ethanol: soluble 50 mg/mL

SMILES string

CCOC(=O)c1ccc(N)cc1

InChI

1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3

InChI key

BLFLLBZGZJTVJG-UHFFFAOYSA-N

General description

Benzocaine is a topical anesthetic. It functions as an appetite suppressant and smoke inhibitor. Benzocaine is used to treat pruritus, burns and cold. It is associated with allergic contact dermatitis.

Application

Benzocaine has been used as an anesthetic in cerebrospinal fluid (CSF) flow analysis. It also has been used as an anesthetic in fishes.


Still not finding the right product?

Explore all of our products under Benzocaine


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Skin Sens. 1

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

233.6 °F

flash_point_c

112 °C

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Fisher's Contact Dermatitis (2008)
Ciliogenesis and cerebrospinal fluid flow in the developing Xenopus brain are regulated by foxj1
Hagenlocher C, et al.
Cilia, 2(1), 12-12 (2013)
Guillaume Castel et al.
Journal of virology, 83(20), 10808-10820 (2009-08-27)
We wanted to develop a therapeutic approach against rabies disease by targeting the lyssavirus transcription/replication complex. Because this complex (nucleoprotein N-RNA template processed by the L polymerase and its cofactor, the phosphoprotein P) is similar to that of other negative-strand



Global Trade Item Number

SKUGTIN
E1501-100G04061835544363
E1501-500G04061835544370